Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Moodys
McKinsey
Express Scripts
Baxter

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PREGABALIN

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Pregabalin

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00035412 St. John's Wort Versus Placebo in Social Phobia Completed National Center for Complementary and Integrative Health (NCCIH) Phase 2 2001-12-01 The purpose of this study is to determine the effectiveness of St. John’s Wort as compared to placebo (an inactive substance) in the treatment of outpatients with social phobia.
NCT00141219 Pregabalin Peripheral Neuropathic Pain Study Completed Pfizer Phase 3 2005-12-01 To evaluate the efficacy of pregabalin, using a flexible, optimized dose schedule with dose adjustment based on Daily Pain Rating Scale (DPRS), compared to placebo in subjects with peripheral neuropathic pain.
NCT00141245 To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. Completed Pfizer Phase 3 1998-10-01 To evaluate long-term safety and efficacy of pregabalin in patients with partial seizures.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Pregabalin

Condition Name

Condition Name for Pregabalin
Intervention Trials
Fibromyalgia 32
Healthy 31
Pain 29
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Pregabalin
Intervention Trials
Neuralgia 77
Pain, Postoperative 49
Fibromyalgia 35
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Pregabalin

Trials by Country

Trials by Country for Pregabalin
Location Trials
Japan 129
Canada 112
India 84
United Kingdom 77
China 73
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Pregabalin
Location Trials
Florida 64
California 63
Texas 58
New York 54
Ohio 51
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Pregabalin

Clinical Trial Phase

Clinical Trial Phase for Pregabalin
Clinical Trial Phase Trials
Phase 4 123
Phase 3 120
Phase 2/Phase 3 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Pregabalin
Clinical Trial Phase Trials
Completed 230
Recruiting 59
Not yet recruiting 34
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Pregabalin

Sponsor Name

Sponsor Name for Pregabalin
Sponsor Trials
Pfizer 158
Tel-Aviv Sourasky Medical Center 5
GL Pharm Tech Corporation 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Pregabalin
Sponsor Trials
Other 275
Industry 224
NIH 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
McKinsey
Dow
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.